Lottery Incentives for Moving
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to learn more about effective ways to motivate people to increase their non-exercise energy expenditure exercise. This is an important research question because obesity and weight-related issues are increasingly becoming a problem in America. This project will address this research question by testing the effect of two different incentive schemes in motivating employees who are predominantly sedentary to use Walkstations at work. The Walkstations are treadmills that move at a very slow rate (maximum 2miles / hour) and are attached to a work station (i.e. with computer and telephone); they therefore are designed to increase energy spent not through heavy exercise, but through small changes in posture and movement associated with routines in daily life (called nonexercise activity thermogenesis or NEAT).
Subjects will be employees of Blue Cross Blue Shield of Massachusetts (BCBSMA). Subjects will be the control participants from the previous Walkstation study we ran with BCBSMA. All 120 control participants from this previous study will be told that they can now participate in a study that involves the Walkstations (up until now, they have not been given access to the Walkstations). These participants from the previous study will be sent an email informing them that they are eligible to participate in this new Walkstation pilot. Those who are interested in participating will then be invited to sign up for an enrollment session. There will be no incentives for participating in the initial enrollment session. For the 2 month follow-up session, participants will have a chance to win 1 of 3 prizes (1 * $100, 2 * $50) for completing the follow-up.
| Condition | Intervention |
|---|---|
|
Obesity Sedentary Lifestyle |
Behavioral: Incentive to exercise |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Basic Science |
- Walkstation usage [ Time Frame: after approx 60 days ] [ Designated as safety issue: No ]
- Biometric measures [ Time Frame: baseline and 60 days ] [ Designated as safety issue: No ]Height, weight, blood pressure
- Questionnaire [ Time Frame: baseline and 45 days ] [ Designated as safety issue: No ]
| Enrollment: | 212 |
| Study Start Date: | March 2011 |
| Study Completion Date: | August 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Personal incentive
If participants attain their walkstation usage goal, they are entered into bi-weekly lotteries to win money.
|
Behavioral: Incentive to exercise
Participants who attain their walkstation goal will be entered into a draw every two weeks. We are testing the effect of different prizes on walkstation usage.
|
|
Active Comparator: Token incentive
Participants who attain their walkstation usage goal will be entered into a bi-weekly prize to win a token reward.
|
Behavioral: Incentive to exercise
Participants who attain their walkstation goal will be entered into a draw every two weeks. We are testing the effect of different prizes on walkstation usage.
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- must pass ParQ
Exclusion Criteria:
- if fail ParQ
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Michael Norton, Associate Professor, Harvard University |
| ClinicalTrials.gov Identifier: | NCT01278654 History of Changes |
| Other Study ID Numbers: | Walkstation2 |
| Study First Received: | January 18, 2011 |
| Last Updated: | March 15, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Obesity Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013